SecBot SecBot
Insider Cluster (3 insiders) ·Filed Aug 5, 2026

ARQT

Arcutis Biotherapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $171K total
Actionable Insight • Neutral

This cluster is too small to warrant a trading response. Monitor for any larger insider sales or C-suite participation in future filings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$26.43
T+0 close · Aug 5, 2026 · via day close
Latest settled
+21.34%
T+60 · $32.07
Vs SPY
+23.01%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 6 $26.43entry
  2. T+1 · 3mo ago −4.31%α −4.92% · $25.29
  3. T+5 · 3mo ago −2.27%α −3.48% · $25.83
  4. T+20 · 3mo ago −10.48%α −11.08% · $23.66
  5. T+60 · 18d ago +21.34%α +23.01% · $32.07
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three Arcutis insiders (Watanabe, Matsuda, Burnett) sold a total of $171K in open-market sales on August 3, 2026, at ~$26.12/share. The dollar value is trivial relative to the $3.3B market cap (~0.005%), and the cluster is small with no C-suite participation. This is routine liquidity-driven selling, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$171.0K
Insiders
3

Key Facts

  • Three insiders sold a total of 6,560 shares for $171K on August 3, 2026
  • Sales were all open-market (code S) at ~$26.12/share
  • Total value is ~0.005% of Arcutis's $3.3B market cap, immaterial
  • No C-suite executives (CEO, CFO, COO) participated; all filers are 'See Remarks'
  • Cluster is small and isolated; no pattern suggesting 10b5-1 or vesting-driven sales

Financial Impact

Total insider sales of $171K represent ~0.005% of $3.3B market cap, economically trivial

insider ownership

Risk Factors

  • Insider sales could accelerate if stock continues to rise, but current level is routine
  • No indication of negative corporate events from this cluster

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ARQT-1785981669787

Track record

34 reports on ARQT

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
  3. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
  4. Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  5. Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  6. Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
  7. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  8. Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (10h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 5, 2026